
    
      Eligible breast cancer patients with mastectomy and axillary dissection are randomized into 2
      groups:conventional fractionation radiotherapy of 50 Gy in 25 fractions within 5 weeks to
      ipsilateral chest wall and supraclavicular nodal region,and hypofractionation radiotherapy of
      43.5Gy in 15 fractions within 3 weeks to the same region.

      During and after radiotherapy, the patients are followed and the efficacy and toxicities of
      radiotherapy are evaluated.
    
  